DeLoye Dennis
Known title: Executive Vice PresidentCIK: 0001888552
Associated companies
Transaction History
| ASB | ▲ Buy | Option Exercise | 5,000 | $124K | 5/26/2026 | View on chart |
| ASB | ▲ Buy | Option Exercise | 9,299 | $242K | 5/26/2026 | View on chart |
| ASB | ▼ Sell | Open Market | 5,000 | $141K | 5/26/2026 | View on chart |
| ASB | ▼ Sell | Open Market | 9,299 | $263K | 5/26/2026 | View on chart |
| ASB | ▲ Buy | Grant | 7,447 | $187K | 3/9/2026 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 2,384 | $60K | 3/9/2026 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 706 | $21K | 2/8/2026 | View on chart |
| ASB | ▲ Buy | Grant | 2,193 | $60K | 2/1/2026 | View on chart |
| ASB | ▲ Buy | Grant | 5,884 | $126K | 3/10/2025 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 1,883 | $40K | 3/10/2025 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 1,186 | $30K | 2/10/2025 | View on chart |
| ASB | ▲ Buy | Grant | 2,347 | $0 | 1/29/2025 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 1,248 | $25K | 2/9/2024 | View on chart |
| ASB | ▲ Buy | Grant | 2,577 | $0 | 1/30/2024 | View on chart |
| ASB | ▼ Sell | Tax Withholding | 1,268 | $30K | 2/9/2023 | View on chart |
| ASB | ▲ Buy | Grant | 2,486 | $0 | 1/30/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Barclays Raises ASB Price Target to $35, Maintains Overweight
Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.
Barclays Raises ASB Price Target to $35, Maintains Overweight. Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.